W

Wei Chen

Xiamen University

ORCID: 0000-0002-0113-2596

Publishes on SARS-CoV-2 and COVID-19 Research, Virus-based gene therapy research, Viral Infections and Outbreaks Research. 183 papers and 6.2k citations.

PubIndex Score97Top 3%How it's scored

183Publications

6.2kTotal Citations

First publication: 2000First senior author: 2010

SARS-CoV-2 and COVID-19 Research Virus-based gene therapy research Viral Infections and Outbreaks Research COVID-19 Clinical Research Studies Advanced Combustion Engine Technologies

Top publicationsby citations

Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial

Jingxin Li, Tao Zhu, Hongxing Pan et al.|The Lancet Respiratory Medicine|2022

Cited by 172

Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial

Lairun Jin, Fengcai Zhu, Rong Tang et al.|Emerging Microbes & Infections|2022

Cited by 30

Antibody Persistence and Safety through 6 Months after Heterologous Orally Aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously

Lairun Jin, Fengcai Zhu, Rong Tang et al.|medRxiv|2022

Cited by 10

Safety and Immunogenicity of Heterologous Boost Immunisation With an Aerosolized Ad5-nCoV After Two-Dose Priming With an Inactivated SARS-CoV-2 Vaccine CoronaVac in Adults: A Randomised, Open-Label, Parallel-Control Trial

Jingxin Li, Fengcai Zhu, Shipo Wu et al.|SSRN Electronic Journal|2022

Cited by 1